Absorption |
Blood-Brain Barrier | BBB- | 0.9800 |
Human Intestinal Absorption | HIA+ | 0.8638 |
Caco-2 Permeability | Caco2- | 0.6924 |
P-glycoprotein Substrate | Substrate | 0.6958 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7958 |
Inhibitor | 0.8945 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8770 |
Distribution |
Subcellular localization | Lysosome | 0.5166 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8827 |
CYP450 2D6 Substrate | Non-substrate | 0.8150 |
CYP450 3A4 Substrate | Substrate | 0.6303 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7223 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.6963 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8745 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6385 |
CYP450 3A4 Inhibitor | Inhibitor | 0.6840 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7450 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9933 |
Non-inhibitor | 0.8183 |
AMES Toxicity | Non AMES toxic | 0.8285 |
Carcinogens | Non-carcinogens | 0.7895 |
Fish Toxicity | High FHMT | 0.9761 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9716 |
Honey Bee Toxicity | Low HBT | 0.5916 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.4859 |
Carcinogenicity (Three-class) | Non-required | 0.5172 |